Wall to Present Webinar on ANDAs and Hatch-Waxman ActApril 4, 2017
O’Melveny associate Carolyn Wall will speak as part of The Knowledge Group’s “ANDAs and the Hatch-Waxman Act” webcast on April 4, 2017. The presentation will cover cases, trends, and developments to watch for in 2017 in light of the continued rise of Abbreviated New Drug Application (ANDA) filings.
Specifically, Wall will address:
- Jurisdiction in light of Acorda and TC Heartland
- 2016 FDA revisions to ANDA regulations
- Exclusivity after Benicar
- Interaction between district court litigation and post-grant proceedings (and effects of the Trump administration)
Based in O’Melveny’s New York office, Wall is an intellectual property litigator who concentrates her practice on ANDA/Hatch-Waxman and other patent litigation.
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.